144 related articles for article (PubMed ID: 37030131)
21. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
[TBL] [Abstract][Full Text] [Related]
22. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
23. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.
Yan F; Li H; de Almeida JR; Kaczmar JM; Pipkorn P; Zenga J; Richardson MS; Neskey DM; Sharma AK; Day TA; Graboyes EM
Otolaryngol Head Neck Surg; 2021 Oct; 165(4):536-549. PubMed ID: 33618570
[TBL] [Abstract][Full Text] [Related]
24. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
25. Incidence of contralateral-bilateral nodes in the human papillomavirus era.
Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO
Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120
[TBL] [Abstract][Full Text] [Related]
26. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.
Lin BM; Wang H; D'Souza G; Zhang Z; Fakhry C; Joseph AW; Drake VE; Sanguineti G; Westra WH; Pai SI
Cancer; 2013 Oct; 119(19):3462-71. PubMed ID: 23861037
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography performance in predicting extranodal extension in HPV-positive oropharynx cancer.
Faraji F; Aygun N; Coquia SF; Gourin CG; Tan M; Rooper LM; Eisele DW; Fakhry C
Laryngoscope; 2020 Jun; 130(6):1479-1486. PubMed ID: 31411751
[TBL] [Abstract][Full Text] [Related]
28. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
29. Clinical vs Microscopic Extranodal Extension and Survival in Oropharyngeal Carcinoma in the Human Papillomavirus Era.
Gal TJ; O'Brien KJ; Chen Q; Huang B
Otolaryngol Head Neck Surg; 2020 May; 162(5):693-701. PubMed ID: 32151208
[TBL] [Abstract][Full Text] [Related]
30. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.
Psyrri A; Rampias T; Vermorken JB
Ann Oncol; 2014 Nov; 25(11):2101-2115. PubMed ID: 25057165
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of computed tomography features in detecting oropharyngeal squamous cell carcinoma extranodal extension.
Tran NA; Palotai M; Hanna GJ; Schoenfeld JD; Bay CP; Rettig EM; Bunch PM; Juliano AF; Kelly HR; Suh CH; Zander DA; Morales Pinzon A; Kann BH; Huang RY; Haddad RI; Guttmann CRG; Guenette JP
Eur Radiol; 2023 May; 33(5):3693-3703. PubMed ID: 36719493
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma.
Tian S; Ferris MJ; Switchenko JM; Magliocca KR; Cassidy RJ; Jhaveri J; Aiken AH; Baugnon KL; Hudgins PA; Kendi ATK; Patel MR; Saba NF; Curran WJ; Beitler JJ
Head Neck; 2019 Sep; 41(9):3056-3063. PubMed ID: 31046181
[TBL] [Abstract][Full Text] [Related]
34. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
35. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use.
Kompelli AR; Morgan P; Li H; Harris W; Day TA; Neskey DM
Otolaryngol Head Neck Surg; 2019 May; 160(5):855-861. PubMed ID: 30526292
[TBL] [Abstract][Full Text] [Related]
37. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM
AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958
[TBL] [Abstract][Full Text] [Related]
39. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
40. Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins.
Fenlon JB; Hutten RJ; Weil CR; Lloyd S; Cannon DM; Kerrigan K; Cannon RB; Hitchcock YJ
Head Neck; 2022 Mar; 44(3):606-614. PubMed ID: 34931386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]